NMTC2
MCID: THY102
MIFTS: 58

Thyroid Cancer, Nonmedullary, 2 (NMTC2) malady

Categories: Genetic diseases, Rare diseases, Cancer diseases, Endocrine diseases

Aliases & Classifications for Thyroid Cancer, Nonmedullary, 2

About this section

Aliases & Descriptions for Thyroid Cancer, Nonmedullary, 2:

Name: Thyroid Cancer, Nonmedullary, 2 52
Follicular Thyroid Carcinoma 11 48 13 68
Thyroid Carcinoma, Follicular 52 48 12
Thyroid Cancer, Follicular 48 27 68
Follicular Adenocarcinoma, Well Differentiated 11
Follicular Carcinoma of the Thyroid Gland 11
Thyroid Carcinoma, Follicular, Somatic 52
Thyroid Carcinoma, Follicular Somatic 24
Thyroid Cancer, Non-Medullary, 2 70
 
Thyroid Follicular Carcinoma 50
Thyroid Gland Adenocarcinoma 68
Adenocarcinoma, Follicular 39
Follicular Adenocarcinoma 11
Follicular Thyroid Cancer 50
Thyroid Adenocarcinoma 11
Follicular Carcinoma 11
Nmtc2 70
Ftc 48

Characteristics:

HPO:

64
thyroid cancer, nonmedullary, 2:
Inheritance: autosomal dominant inheritance

Classifications:



External Ids:

OMIM52 188470
Disease Ontology11 DOID:3962
NCIt45 C8054
MedGen37 C0206682

Summaries for Thyroid Cancer, Nonmedullary, 2

About this section
OMIM:52 Nonmedullary thyroid cancer (NMTC) comprises thyroid cancers of follicular cell origin and accounts for more than 95%... (188470) more...

MalaCards based summary: Thyroid Cancer, Nonmedullary, 2, also known as follicular thyroid carcinoma, is related to familial papillary or follicular thyroid carcinoma and trabecular follicular adenocarcinoma, and has symptoms including abnormality of metabolism/homeostasis, follicular thyroid carcinoma and non-medullary thyroid carcinoma. An important gene associated with Thyroid Cancer, Nonmedullary, 2 is SRGAP1 (SLIT-ROBO Rho GTPase Activating Protein 1), and among its related pathways are p38MAPK events and PI3K-AKT-mTOR signaling pathway and therapeutic opportunities. Affiliated tissues include thyroid, lung and lymph node, and related mouse phenotypes are Decreased viability and hearing/vestibular/ear.

UniProtKB/Swiss-Prot:70 Thyroid cancer, non-medullary, 2: A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms.

Disease Ontology:11 A thyroid carcinoma that has material basis in follicular cells.

Related Diseases for Thyroid Cancer, Nonmedullary, 2

About this section

Diseases in the Thyroid Cancer, Nonmedullary, 2 family:

Thyroid Cancer, Nonmedullary, 4 Thyroid Cancer, Nonmedullary, 5

Diseases related to Thyroid Cancer, Nonmedullary, 2 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 69)
idRelated DiseaseScoreTop Affiliating Genes
1familial papillary or follicular thyroid carcinoma12.0
2trabecular follicular adenocarcinoma11.9
3papillary follicular thyroid adenocarcinoma11.8
4differentiated thyroid carcinoma11.3
5medullary thyroid carcinoma, familial11.0
6thyroid carcinoma, hurthle cell11.0
7thyroid cancer, monmedullary, 110.9
8tumoral calcinosis, hyperphosphatemic, familial10.8
9thyroid cancer10.8
10parotid gland adenoid cystic carcinoma10.4HRAS, NRAS, PTEN
11mesocardia10.3PAX8, TG, TSHR
12acute disseminated encephalomyelitis10.3BRAF, NRAS, PTEN
13background diabetic retinopathy10.3TG, TPO, TSHR
14endophthalmitis10.3CALCA, TG
15cowden syndrome 310.3CALCA, RET, TG
16tick paralysis10.3TG, THRB, TPO
17conjunctival deposit10.3TG, TPO, TSHR
18mixed eosinophil-basophil adenoma10.3TG, TPO, TSHR
19childhood teratocarcinoma of the testis10.3CALCA, PTEN, RET, TG
20bizarre leiomyoma10.3CALCA, NKX2-1, TG
21monostotic fibrous dysplasia10.3BRAF, LGALS3, PTEN
22acute hemorrhagic encephalitis10.3HRAS, NRAS, RET, TG, TSHR
23hypothyroidism, congenital, nongoitrous, 110.3TG, THRB, TPO, TSHR
24neuhauser daly magnelli syndrome10.3PAX8, TG, TPO, TSHR
25krabbe disease10.3CALCA, TG, TPO, TSHR
26endemic goiter10.3CALCA, TG, TPO, TSHR
27denys-drash syndrome10.3TG, TPO, TSHR
28neutropenia, severe congenital, 5, autosomal recessive10.3CALCA, NKX2-1, RET, TG
29malignant pleural solitary fibrous tumor10.3HRAS, NKX2-1, NRAS, PTEN
30glomangiomyoma10.3TG, THRB, TPO, TSHR
31urinary tract papillary transitional cell benign neoplasm10.3CALCA, NKX2-1, RET
32janus kinase-3 deficiency10.2TG, TPO, TSHR
33pseudomonas stutzeri infections10.2BRAF, NRAS
34gastrinoma10.2CALCA, NKX2-1, RET, TG, TSHR
35trigonocephaly, nonsyndromic10.2BRAF, RET
36glomeruloid hemangioma10.2BRAF, HRAS, KDR, NRAS, PTEN
37neuronopathy, distal hereditary motor, type viia10.2LGALS3, NKX2-1, PAX8, TG, TSHR
38parachordoma10.2BRAF, NKX2-1, RET, TG, TSHR
39tmem70 defect10.2BRAF, NKX2-1, PAX8, RET, TG
40thyroiditis10.2
41broad ligament malignant neoplasm10.2CALCA, DIO2, TG, TPO, TSHR
42commensal bacterial infectious disease10.2NKX2-1, PAX8, TG, TPO, TSHR
43infertility10.2HRAS, LGALS3, NKX2-1, NRAS, RET, TG
44dihydrolipoamide dehydrogenase deficiency10.2PAX8, TG, TPO
45pulsating exophthalmos10.2DIO2, TG, THRB, TPO, TSHR
46autoimmune hemolytic anemia10.2CALCA, RET, TG, THRB, TPO, TSHR
47progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 310.2BRAF, HRAS, LGALS3, NME1, NRAS, PTEN
48cholesterol embolism10.1NKX2-1, PAX8, TG, THRB, TPO, TSHR
49benign shuddering attacks10.1CALCA, HRAS, KDR, LGALS3, PAX8, RET
50lattice corneal dystrophy10.1BRAF, NME1, NRAS

Graphical network of the top 20 diseases related to Thyroid Cancer, Nonmedullary, 2:



Diseases related to thyroid cancer, nonmedullary, 2

Symptoms & Phenotypes for Thyroid Cancer, Nonmedullary, 2

About this section

Symptoms by clinical synopsis from OMIM:

188470

Clinical features from OMIM:

188470

Human phenotypes related to Thyroid Cancer, Nonmedullary, 2:

 64
id Description HPO Frequency HPO Source Accession
1 abnormality of metabolism/homeostasis64 HP:0001939
2 follicular thyroid carcinoma64 HP:0006731
3 non-medullary thyroid carcinoma64 HP:0040198

GenomeRNAi Phenotypes related to Thyroid Cancer, Nonmedullary, 2 according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00381-A-110.2HRAS, KDR, NRAS, PPARG, RET

MGI Mouse Phenotypes related to Thyroid Cancer, Nonmedullary, 2 according to GeneCards Suite gene sharing:

41 (show all 23)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053779.9BRAF, PAX8, PPARG, THRB, TPO, TSHR
2MP:00053719.7NRAS, PAX8, PTEN, RET, THRB, TPO
3MP:00053679.6BRAF, DIO2, HRAS, LGALS3, PAX8, PPARG
4MP:00053899.5BRAF, LGALS3, NKX2-1, PAX8, PPARG, PTEN
5MP:00053919.4BRAF, KDR, NRAS, PAX8, PPARG, PTEN
6MP:00053889.4BRAF, HRAS, KDR, LGALS3, NKX2-1, PTEN
7MP:00030129.3HRAS, KDR, NKX2-1, NRAS, PAX8, PPARG
8MP:00107719.3BRAF, HRAS, KDR, LGALS3, NME1, NRAS
9MP:00053819.2BRAF, DIO2, LGALS3, NKX2-1, NRAS, PTEN
10MP:00020069.1BRAF, HRAS, LGALS3, NKX2-1, NME1, NRAS
11MP:00028739.0BRAF, HRAS, KDR, MINPP1, NKX2-1, NRAS
12MP:00053709.0BRAF, KDR, LGALS3, NME1, NRAS, PPARG
13MP:00053869.0BRAF, HRAS, KDR, LGALS3, NKX2-1, NRAS
14MP:00053849.0BRAF, KDR, LGALS3, NKX2-1, NRAS, PAX8
15MP:00053878.9BRAF, KDR, LGALS3, NRAS, PPARG, PTEN
16MP:00053908.8BRAF, DIO2, HRAS, KDR, LGALS3, NKX2-1
17MP:00053858.8BRAF, HRAS, KDR, LGALS3, NKX2-1, NRAS
18MP:00053978.8BRAF, KDR, LGALS3, NRAS, PPARG, PTEN
19MP:00053788.3BRAF, DIO2, HRAS, KDR, NKX2-1, NME1
20MP:00107688.3BRAF, HRAS, KDR, LGALS3, NKX2-1, NME1
21MP:00053768.2BRAF, DIO2, HRAS, KDR, LGALS3, NKX2-1
22MP:00053798.2BRAF, DIO2, HRAS, NKX2-1, NME1, NRAS
23MP:00036318.1BRAF, HRAS, KDR, LGALS3, NKX2-1, NME1

Drugs & Therapeutics for Thyroid Cancer, Nonmedullary, 2

About this section

Drugs for Thyroid Cancer, Nonmedullary, 2 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 252)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
HydroxocobalaminapprovedPhase 425813422-51-011953898, 5460373, 44475014
Synonyms:
13422-51-0
22465-48-1
78091-12-0
8017-22-9
Acti-B12
AlphaRedisol
AlphaRedisol (TN)
Axion
Axlon
Benzimidazolyl ribofuranosyl phosphate deriv.
C08230
C62H85CoN13O15P
CHEBI:27786
CHEMBL1200742
CHEMBL235822
CID11622291
CID11953898
CID5460373
CID6433575
CID6474319
Ciplamin H
Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-hydroxocobamide
Cobalex
Cobalin H
Cobinamide dihydroxide dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Cobinamide, Co-hydroxy-, dihydrogen phosphate (ester), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono (inner salt), 3'- ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Codroxomin
Cyanokit
Cyanokit (TN)
D01027
DB00200
Depogamma
Docclan
Docelan
Docelvita
Docevita
Droxomin
Ducobee Hy
Ducobee-Hy
Duradoce
Duralta-12
EINECS 236-533-2
HSDB 3342
HYDROXOCOBALAMIN
Hidroxocobalamina
Hidroxocobalamina [INN-Spanish]
Hydro Cobex
 
Hydrobamine
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxocobalamin (JAN/USP/INN)
Hydroxocobalamin Vitamin B12
Hydroxocobalamin [USAN:INN:BAN:JAN]
Hydroxocobalamin acetate
Hydroxocobalamin anhydrous
Hydroxocobalamin monohydrochloride
Hydroxocobalamin(alkaline soln.), OH- replaces CN- in Cyanocobalamin)
Hydroxocobalaminacetat
Hydroxocobalamine
Hydroxocobalamine [INN-French]
Hydroxocobalaminum
Hydroxocobalaminum [INN-Latin]
Hydroxocobalaminum anhydrous
Hydroxocobemine
Hydroxomin
Hydroxy Cobal
Hydroxy vitamin B12
Hydroxycob(lll)alamin
Hydroxycobalamin
Hydroxycobalamine
Hyxobamine
Idrogrisevit
Idrossocobalamina
Idrossocobalamina [DCIT]
LS-54607
Lyovit-H
Neo-Betalin 12
Neo-cytamen
Neo-macrabin
Neo-rojamin
OH-Cbl
OH-Duphar
Ohb12
Oxobemin
Oxolamine (arcum)
Primabalt RP
Redisol-H
S1668_Selleck
Sytobex-H
UNII-Q40X8H422O
Vibeden
Vitadurin
Vitamin B(sub 12a)
Vitamin B-12b
Vitamin B12a
Vitamin B12b
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
vitamin B-12b
2
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 3, Phase 2439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
3
leucovorinapproved, NutraceuticalPhase 4, Phase 2323558-05-954575, 6560146, 143
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyl-THF
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
4
Manganeseapproved, nutraceuticalPhase 4347439-96-527854
Synonyms:
 
Manganese
5
Cyanocobalaminapproved, nutraceuticalPhase 425968-19-944176380
Synonyms:
Anacobin
Bedoz
Berocca PN
Berubigen
Betalin 12
Betalin 12 Crystalline
Betaline-12
Betolvex
Bevidox
Bevidox concentrate
Biocobalamine
Byladoce
Cabadon m
Cernevit-12
Cobadoce forte
Cobalin
Cobavite
Cobex
Cobolin-M
Copharvit 5000
Covit
Crystamin
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-B12
Cyanobalamin concentrate
Cyanocob(III)alamin
Cyanocobalamin (JP15/USP)
Cyanocobalamin Co 57 Schilling Test Kit
Cyanocobalamine
Cyanocobalmin
Cyanoject
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dicopac Kit
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
Duodecibin
Embiol
Emociclina
Eritrone
Erycytol
 
Erythrotin
Euhaemon
Extrinsic factor
Factor II
Fermin
Fresmin
Hemomin
Hepagon
Hepavis
Hepcovite
Hylugel plus
Infuvite Pediatric
Lactobacillus lactis dorner factor
M.V.I. Pediatric
Macrabin
Megabion
Megalovel
Milbedoce
Millevit
Nagravon
Nascobal
Nascobal (TN)
Neuroforte-R
Normocytin
Novidroxin
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
Rubivite
Rubramin
Rubramin PC
Rubratope-57 Kit
Rubratope-60 Kit
Rubripca
Rubrocitol
Ruvite
Shovite
Sytobex
Vi-Twel
Vibal
Vibalt
Vibisone
Virubra
Vita-rubra
Vitabee 12
Vitamin B12
Vitamin B12 Preparation
Vitamin B12 complex
Vitaped
Vitarubin
Vitral
vitamine b12
6Vitamin B ComplexPhase 4, Phase 3, Phase 24337
7Hypoglycemic AgentsPhase 4, Phase 2, Phase 1, Early Phase 15896
8VitaminsPhase 4, Phase 3, Phase 25282
9
IodinePhase 4, Phase 3, Phase 2, Phase 15707553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
10Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 113168
11Trace ElementsPhase 4, Phase 3, Phase 2, Phase 16001
12Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 113180
13cadexomer iodinePhase 4, Phase 3, Phase 2, Phase 1537
14HormonesPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 114415
15Vitamin B 12Phase 4259
16insulinPhase 44646
17Insulin, Globin ZincPhase 44645
18HematinicsPhase 41684
19MicronutrientsPhase 4, Phase 3, Phase 2, Phase 16001
20Vitamin B9NutraceuticalPhase 4, Phase 3, Phase 24392
21FolateNutraceuticalPhase 4, Phase 3, Phase 24392
22Vitamin B12NutraceuticalPhase 4259
23
CobalaminNutraceuticalPhase 425913408-78-16438156
Synonyms:
5,6-Dimethyl-1-a-D-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-a-D-ribofuranosylbenzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosylbenzimidazole
Cob(III)alamin
Cobalamin (III)
Cobalamine
 
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
Hydroxomin
Rubivite
Rubratope-57
Rubratope-60
Ruvite
Vitamin B12
24
Methylcobalaminexperimental, NutraceuticalPhase 426013422-55-4
Synonyms:
Algobaz
Co-Methylcobalamin
Co-methylcobalamin
Hitocobamin M
MeCbl
Mecobalamin
Methycobal
 
Methyl cobalamine
Methyl vitamin B12
Methyl-5,6-dimethylbenzimidazolylcobalamin
Methyl-B12
Methylcob(III)alamin
Methylcobalamin
Methylcobaz
mecobalamin
methyl(III)cobalamin
25InositolNutraceuticalPhase 487
26
Sorafenibapproved, investigationalPhase 3, Phase 2700284461-73-0216239, 406563
Synonyms:
284461-73-0
4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE
AB1004622
AC-1674
AC1L50CF
BAX
BAY 43-9006
BAY 43-9006 (free base)
BAY 43-9006 tosylate salt
BAY 439006
BAY 54-9085 (tosylate salt)
BAY-43-0006
BAY-43-9006
BAY-54-9085
BAY43-9006
BRD-K23984367-001-01-8
Bio-0100
CHEBI:47228
CHEBI:50924
CHEMBL1336
CID216239
 
D08524
DB00398
DB07438
EN002709
I06-0856
K00597a
Kinome_766
LS-186067
LS-187021
LS-187788
MolPort-003-850-270
N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
NCGC00167488-01
NSC-724772
NSC747971
Nexavar
STK627350
Sorafenib
Sorafenib (INN)
Sorafenib [INN]
Sorafenib tosylate
Sorafenibum
UNII-9ZOQ3TZI87
ZINC01493878
nchembio.117-comp17
sorafenib
sorafenibum
27
rituximabapprovedPhase 3, Phase 11692174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
28
Salmon Calcitoninapproved, investigationalPhase 3, Phase 29547931-85-116129616
Synonyms:
135506-95-5
47931-85-1
Astronin
Biocalcin
Bionocalcin
C028815
C06865
C145H239N43O48S2
CALCITONIN, SALMON
Cadens
Calciben
Calcihexal
Calcimar
Calcimar (TN)
Calcimonta
Calcinil
Calcioton
Calcitonin (Salmon Synthetic)
Calcitonin (salmon)
Calcitonin 1 precursor
Calcitonin Salmon
Calcitonin [USAN:INN:BAN:JAN]
Calcitonin salmon
Calcitonin salmon (USAN/INN)
Calcitonin salmon (synthesis)
Calcitonin salmon (synthesis) (JAN)
Calcitonin salmon recombinant
Calcitonin vom lachs
Calcitonin, salmar
Calcitonin, salmon
Calcitonin, salmon, for bioassay
Calcitonin,salmon
Calcitonin-salmon
Calcitonina
Calcitonine de saumon
Calcitoran
Calco
Calogen
Calsynar
Calsynar Lyo L
Caltine
Casalm
Catonin
Cibacalcin
Cibacalcine
Citonina
 
D00249
EINECS 256-342-8
Eptacalcin
Forcaltonin
Fortical
Fortical (TN)
Ipocalcin
Isi-calcin
Kalsimin
Karil
LS-48624
Miacalcic
Miacalcin
Miacalcin (TN)
Miracalcic
Oseototal
Osseocalcina
Osteobion
Osteovis
Ostosalm
Ostostabil
Porostenina
Prontocalcin
Quosten
Riostin
Rulicalcin
Salcat
Salcatonin
Salcatyn
Salmocalcin
Salmofar
Salmon calcitonin
Salmon calcitonin I
Salmon calcitonin-(I-32)
Salmotonin
Sical
Stalcin
Staporos
Steocin
TZ-CT
Thyrocalcitonin (salmon)
Tonocalcin
UNII-7SFC6U2VI5
Ucecal
recombinant salmon calcitonin
salmon calcitonin (1-32)
synthetic salmon calcitonin
29
Progesteroneapproved, vet_approvedPhase 3, Early Phase 155957-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
30
Fentanylapproved, illicit, investigational, vet_approvedPhase 3821437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
1-phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl CII
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
 
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
UNII-UF599785JZ
fentanyl
31
Niacinapproved, investigational, nutraceuticalPhase 3, Phase 292359-67-6938
Synonyms:
3-Carboxylpyridine
3-Carboxypyridine
3-Pyridinecarboxylate
3-Pyridinecarboxylic acid
3-Pyridylcarboxylate
3-Pyridylcarboxylic acid
3-carboxypyridine
Acide Nicotinique
Acido nicotinico
Acidum Nicotinicum
Akotin
Anti-pellagra vitamin
Apelagrin
Daskil
Efacin
Enduracin
Linic
M-Pyridinecarboxylic Acid
Niac
Niacin
Niacine
Niacor
Nicacid
Nicamin
Nicangin
 
Nico-Span
Nicobid
Nicocap
Nicodelmine
Nicolar
Niconacid
Nicosan 3
Nicotinate
Nicotinic Acid
Nicotinic acid
Nicotinipca
Nicyl
Nikotinsaeure
Nyclin
P.P. factor
PP Factor
Pellagra preventive factor
Pellagrin
Pelonin
Pyridine-beta-carboxylic acid
Slo-niacin
Vitamin B3
Wampocap
beta-Pyridinecarboxylic acid
pyridine-β-carboxylic acid
β-pyridinecarboxylic acid
32
Cholecalciferolapproved, nutraceuticalPhase 3, Phase 287567-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
Colecalciferol
 
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D-3
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
cholecalciferol
colecalciferolum
vitamin d-3
33
Nicotinamideapproved, NutraceuticalPhase 3, Phase 291998-92-0936
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
37321-14-5
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC-907/25014114
AC1L1ACZ
AC1Q4ZFV
AI3-02906
Acid amide
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra Brand of Niacinamide
Austrovit PP
B 3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin Amide
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
Hansamid
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
LS-2051
MLS000069714
Mediatric
Merck Brand of Niacinamide
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
NCGC00093354-03
NCGC00093354-04
NSC 13128
NSC13128
NSC27452
Nandervit-N
Niacevit
Niacinamide
Niacinamide (USP)
Niacinamide Astra Brand
Niacinamide Jenapharm Brand
Niacinamide Merck Brand
 
Niacinamide Pharmagenix Brand
Niacinamide [USAN]
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid Jenapharm
Nicotinsaureamid [German]
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
PP-Faktor
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix Brand of Niacinamide
Propamine A
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
SGCUT00176
SMR000058212
Savacotyl
UNII-25X51I8RD4
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin B 3
Vitamin B3 amide
Vitamin H1
Vitamin PP
WLN: T6NJ CVZ
Witamina PP
ZINC00005878
b-Pyridinecarboxamide
beta-Pyridinecarboxamide
bmse000281
m-(Aminocarbonyl)pyridine
nchembio.154-comp4
nchembio.73-comp6
niacin - Vitamin B3
niacinamide
nicotinamide
pyridine-3-carboxamide
to_000073
vitamin PP
34
Ergocalciferolapproved, nutraceuticalPhase 3128150-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
35Anti-Infective AgentsPhase 3, Phase 2, Phase 122062
36Antirheumatic AgentsPhase 3, Phase 2, Phase 110956
37Liver ExtractsPhase 3, Phase 2, Phase 14067
38Bone Density Conservation AgentsPhase 3, Phase 23376
39AnalgesicsPhase 3, Phase 211733
40Analgesics, OpioidPhase 33238
41Nicotinic AcidsPhase 3, Phase 2923
42Calcitonin Gene-Related PeptidePhase 3, Phase 295
43vitamin dPhase 3, Phase 21724
44Anesthetics, GeneralPhase 32934
45ProgestinsPhase 3, Early Phase 1564
46calcitoninPhase 3, Phase 2107
47Iodine-131 anti-B1 antibodyPhase 3, Phase 252
48Protein Kinase InhibitorsPhase 3, Phase 2, Phase 13689
49Adjuvants, AnesthesiaPhase 31674
50NarcoticsPhase 33646

Interventional clinical trials:

(show top 50)    (show all 115)
idNameStatusNCT IDPhase
1Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound ParametersCompletedNCT01514942Phase 4
2Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.CompletedNCT00001730Phase 4
3A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.CompletedNCT00295763Phase 3
4Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3
5Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins LymphomaCompletedNCT00268983Phase 3
6IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer PatientsRecruitingNCT01398085Phase 2, Phase 3
7Iodine I 131 With or Without Thyroid-Stimulating Hormone in Treating Patients Who Have Undergone Surgery for Thyroid CancerActive, not recruitingNCT00415233Phase 3
8Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid CancerActive, not recruitingNCT00984282Phase 3
9Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast CancerActive, not recruitingNCT01608451Phase 3
10Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid CancerUnknown statusNCT00098852Phase 2
11Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid CancerUnknown statusNCT01118065Phase 2
12External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesUnknown statusNCT00637637Phase 2
13Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid CancerUnknown statusNCT00786552Phase 2
14Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131CompletedNCT00085293Phase 2
15Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine TherapyCompletedNCT00104871Phase 2
16Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid CancerCompletedNCT00251316Phase 2
17Thalidomide in Treating Patients With Thyroid CancerCompletedNCT00026533Phase 2
18Sutent Adjunctive Treatment of Differentiated Thyroid CancerCompletedNCT00668811Phase 2
19Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive IodineCompletedNCT00098813Phase 2
20Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine TherapyCompletedNCT00729157Phase 2
21Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid CancerCompletedNCT00118248Phase 2
22Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerCompletedNCT00519896Phase 2
23Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid CancerCompletedNCT00134043Phase 2
24Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid CancerCompletedNCT00061906Phase 2
25Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine TherapyCompletedNCT00095836Phase 2
26Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerCompletedNCT01164176Phase 2
27A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid CancerCompletedNCT00121628Phase 2
28Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsCompletedNCT00002608Phase 2
29Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
30A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...CompletedNCT00923481Phase 2
31Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerCompletedNCT00787761Phase 2
32Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerCompletedNCT00365287Phase 1, Phase 2
33Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonCompletedNCT00010283Phase 1, Phase 2
34Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsCompletedNCT00004157Phase 2
35Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationCompletedNCT00003887Phase 2
36Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerCompletedNCT00003408Phase 2
37A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell OriginCompletedNCT01182285Phase 2
38Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive IodineCompletedNCT00559949Phase 2
39Study Of AG-013736 In Patients With 131I-Refractory Thyroid CancerCompletedNCT00389441Phase 2
40Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 TositumomabCompletedNCT00933335Phase 2
41Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell TransplantCompletedNCT00321932Phase 2
42Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid CarcinomaCompletedNCT00887107Phase 2
43Phase I/II Study of IMMU-132 in Patients With Epithelial CancersRecruitingNCT01631552Phase 1, Phase 2
44Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid CancerRecruitingNCT02152995Phase 2
45Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid CancerRecruitingNCT02393690Phase 2
46Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical StudyRecruitingNCT02084732Phase 2
47REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid CarcinomasActive, not recruitingNCT00287287Phase 2
48Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid CancerActive, not recruitingNCT00537095Phase 2
49Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid CancerActive, not recruitingNCT01723202Phase 2
50Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid CancerActive, not recruitingNCT01208051Phase 1, Phase 2

Search NIH Clinical Center for Thyroid Cancer, Nonmedullary, 2


Cochrane evidence based reviews: adenocarcinoma, follicular

Genetic Tests for Thyroid Cancer, Nonmedullary, 2

About this section

Genetic tests related to Thyroid Cancer, Nonmedullary, 2:

id Genetic test Affiliating Genes
1 Thyroid Cancer, Follicular27
2 Follicular Thyroid Carcinoma27
3 Thyroid Carcinoma, Follicular Somatic24 PTEN

Anatomical Context for Thyroid Cancer, Nonmedullary, 2

About this section

MalaCards organs/tissues related to Thyroid Cancer, Nonmedullary, 2:

36
Thyroid, Lung, Lymph node, Bone

Publications for Thyroid Cancer, Nonmedullary, 2

About this section

Variations for Thyroid Cancer, Nonmedullary, 2

About this section

UniProtKB/Swiss-Prot genetic disease variations for Thyroid Cancer, Nonmedullary, 2:

70
id Symbol AA change Variation ID SNP ID
1HRASp.Gln61LysVAR_045979rs28933406
2MINPP1p.Ser41LeuVAR_022836rs119486096
3MINPP1p.Gln270ArgVAR_022837rs104894171
4NRASp.Gln61ArgVAR_006847rs11554290
5SRGAP1p.Gln149HisVAR_075879rs781626187
6SRGAP1p.Ala275ThrVAR_075880rs797044990
7SRGAP1p.Arg617CysVAR_075882rs114817817
8SRGAP1p.His875ArgVAR_075883rs61754221

Clinvar genetic disease variations for Thyroid Cancer, Nonmedullary, 2:

5
id Gene Variation Type Significance SNP ID Assembly Location
1HRASNM_ 005343.3(HRAS): c.181C> A (p.Gln61Lys)SNVPathogenic/ Likely pathogenicrs28933406GRCh37Chr 11, 533875: 533875
2NRASNM_ 002524.4(NRAS): c.182A> G (p.Gln61Arg)SNVPathogenic/ Likely pathogenicrs11554290GRCh37Chr 1, 115256529: 115256529
3BRAFNM_ 004333.4(BRAF): c.1801A> G (p.Lys601Glu)SNVPathogenic/ Likely pathogenicrs121913364GRCh37Chr 7, 140453134: 140453134
4SRGAP1NM_ 020762.3(SRGAP1): c.447A> C (p.Gln149His)SNVPathogenicrs781626187GRCh38Chr 12, 64016970: 64016970
5SRGAP1NM_ 020762.3(SRGAP1): c.823G> A (p.Ala275Thr)SNVPathogenicrs797044990GRCh38Chr 12, 64062938: 64062938
6SRGAP1NM_ 020762.3(SRGAP1): c.1849C> T (p.Arg617Cys)SNVrisk factorrs114817817GRCh37Chr 12, 64502747: 64502747
7MINPP1NM_ 004897.4(MINPP1): c.122C> T (p.Ser41Leu)SNVPathogenicrs119486096GRCh37Chr 10, 89264794: 89264794
8MINPP1NM_ 004897.4(MINPP1): c.809A> G (p.Gln270Arg)SNVPathogenicrs104894171GRCh37Chr 10, 89268264: 89268264

Cosmic variations for Thyroid Cancer, Nonmedullary, 2:

8 (show top 50)    (show all 154)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1COSM580NRASthyroid,NS,carcinoma,follicular carcinomac.181C>Ap.Q61K29
2COSM476BRAFthyroid,NS,carcinoma,follicular carcinomac.1799T>Ap.V600E29
3COSM584NRASthyroid,NS,carcinoma,follicular carcinomac.182A>Gp.Q61R29
4COSM26449TSHRthyroid,NS,carcinoma,follicular carcinomac.1358T>Cp.M453T29
5COSM551KRASthyroid,NS,carcinoma,follicular carcinomac.182A>Cp.Q61P29
6COSM499HRASthyroid,NS,carcinoma,follicular carcinomac.182A>Gp.Q61R29
7COSM552KRASthyroid,NS,carcinoma,follicular carcinomac.182A>Gp.Q61R29
8COSM500HRASthyroid,NS,carcinoma,follicular carcinomac.182A>Cp.Q61P29
9COSM5224PTENthyroid,NS,carcinoma,follicular carcinomac.370T>Ap.C124S29
10COSM28547PIK3CAthyroid,NS,carcinoma,follicular carcinomac.3180C>Tp.H1060H29
11COSM23654PTENthyroid,NS,carcinoma,follicular carcinomac.701G>Ap.R234Q29
12COSM496HRASthyroid,NS,carcinoma,follicular carcinomac.181C>Ap.Q61K29
13COSM478BRAFthyroid,NS,carcinoma,follicular carcinomac.1801A>Gp.K601E29
14COSM1570338RETthyroid,NS,carcinoma,follicular carcinomac.2651A>Tp.E884V29
15COSM760PIK3CAthyroid,NS,carcinoma,follicular carcinomac.1624G>Ap.E542K29
16COSM483HRASthyroid,NS,carcinoma,follicular carcinomac.35G>Tp.G12V29
17COSM29097PIK3CAthyroid,NS,carcinoma,follicular carcinomac.1649T>Cp.F550S29
18COSM516KRASthyroid,NS,carcinoma,follicular carcinomac.34G>Tp.G12C29
19COSM23651PTENthyroid,NS,carcinoma,follicular carcinomac.353A>Gp.H118R29
20COSM5546623RB1thyroid,NS,carcinoma,follicular carcinomac.2039T>Cp.I680T29
21COSM532KRASthyroid,NS,carcinoma,follicular carcinomac.38G>Ap.G13D29
22COSM96532IDH1thyroid,NS,carcinoma,follicular carcinomac.390A>Gp.I130M29
23COSM13224CDKN2Athyroid,NS,carcinoma,follicular carcinomac.242C>Tp.P81L29
24COSM96531IDH1thyroid,NS,carcinoma,follicular carcinomac.209G>Ap.G70D29
25COSM33598PIK3CAthyroid,NS,carcinoma,follicular carcinomac.3002T>Ap.L1001H29
26COSM522KRASthyroid,NS,carcinoma,follicular carcinomac.35G>Cp.G12A29
27COSM33600PIK3CAthyroid,NS,carcinoma,follicular carcinomac.3046T>Cp.F1016L29
28COSM485HRASthyroid,NS,carcinoma,follicular carcinomac.35G>Cp.G12A29
29COSM26419TSHRthyroid,NS,carcinoma,follicular carcinomac.1897G>Tp.D633Y29
30COSM97131IDH1thyroid,NS,carcinoma,follicular carcinomac.532G>Ap.V178I29
31COSM1203589DICER1thyroid,NS,carcinoma,follicular carcinomac.5437G>Cp.E1813Q29
32COSM29095PIK3CAthyroid,NS,carcinoma,follicular carcinomac.3001C>Ap.L1001I29
33COSM583NRASthyroid,NS,carcinoma,follicular carcinomac.182A>Tp.Q61L29
34COSM26416TSHRthyroid,NS,carcinoma,follicular carcinomac.1867G>Tp.A623S29
35COSM1570337ALKthyroid,NS,carcinoma,follicular carcinomac.3551G>Ap.G1184E29
36COSM521KRASthyroid,NS,carcinoma,follicular carcinomac.35G>Ap.G12D29
37COSM484HRASthyroid,NS,carcinoma,follicular carcinomac.35G>Ap.G12D29
38COSM26450TSHRthyroid,NS,carcinoma,follicular carcinomac.1456A>Tp.I486F29
39COSM12458PIK3CAthyroid,NS,carcinoma,follicular carcinomac.1634A>Cp.E545A29
40COSM28544PIK3CAthyroid,NS,carcinoma,follicular carcinomac.3026G>Ap.G1009E29
41COSM23652PTENthyroid,NS,carcinoma,follicular carcinomac.496G>Ap.V166I29
42COSM33599PIK3CAthyroid,NS,carcinoma,follicular carcinomac.3052G>Ap.D1018N29
43COSM29096PIK3CAthyroid,NS,carcinoma,follicular carcinomac.1558G>Ap.D520N29
44COSM23653PTENthyroid,NS,carcinoma,follicular carcinomac.476G>Ap.R159K29
45COSM33601PIK3CAthyroid,NS,carcinoma,follicular carcinomac.3155C>Tp.T1052I29
46COSM5033PTENthyroid,NS,carcinoma,follicular carcinomac.389G>Ap.R130Q29
47COSM498HRASthyroid,NS,carcinoma,follicular carcinomac.182A>Tp.Q61L29
48COSM26485TSHRthyroid,NS,carcinoma,follicular carcinomac.1894A>Gp.T632A29
49COSM707METthyroid,NS,carcinoma,follicular carcinomac.3029C>Tp.T1010I29
50COSM520KRASthyroid,NS,carcinoma,follicular carcinomac.35G>Tp.G12V29

Expression for genes affiliated with Thyroid Cancer, Nonmedullary, 2

About this section
Search GEO for disease gene expression data for Thyroid Cancer, Nonmedullary, 2.

Pathways for genes affiliated with Thyroid Cancer, Nonmedullary, 2

About this section

Pathways related to Thyroid Cancer, Nonmedullary, 2 according to GeneCards Suite gene sharing:

(show all 26)
idSuper pathwaysScoreTop Affiliating Genes
110.2HRAS, NRAS
210.1HRAS, NRAS, PTEN
310.1HRAS, NRAS, RET
410.0BRAF, HRAS, NRAS
5
Show member pathways
10.0BRAF, HRAS, NRAS
610.0BRAF, HRAS, NRAS
710.0TG, TPO, TSHR
810.0HRAS, NRAS, PTEN, RET
9
Show member pathways
9.9HRAS, KDR, NRAS, PTEN
10
Show member pathways
9.9BRAF, HRAS, NRAS, PTEN
11
Show member pathways
9.9BRAF, HRAS, NRAS, PTEN
12
Show member pathways
9.9BRAF, HRAS, NRAS, PTEN
139.9BRAF, HRAS, NRAS, PTEN
149.9DIO2, HRAS, NRAS, THRB
15
Show member pathways
9.9BRAF, HRAS, NRAS, PPARG
16
Show member pathways
9.9BRAF, HRAS, NRAS, PPARG
179.9BRAF, HRAS, KDR, NRAS
189.9BRAF, HRAS, PAX8, TSHR
19
Show member pathways
9.8BRAF, HRAS, NRAS, RASSF1
20
Show member pathways
9.8PAX8, TG, TPO, TSHR
21
Show member pathways
9.7BRAF, HRAS, KDR, NRAS, PTEN
22
Show member pathways
9.7BRAF, HRAS, KDR, NRAS, RET
23
Show member pathways
9.7BRAF, HRAS, KDR, NRAS, RASSF1
249.6BRAF, HRAS, NRAS, PAX8, PPARG, RET
25
Show member pathways
9.5BRAF, HRAS, KDR, NRAS, PTEN, RASSF1
269.3BRAF, HRAS, NRAS, PAX8, PPARG, PTEN

GO Terms for genes affiliated with Thyroid Cancer, Nonmedullary, 2

About this section

Biological processes related to Thyroid Cancer, Nonmedullary, 2 according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of adenylate cyclase activityGO:004576210.9CALCA, TSHR
2regulation of axon regenerationGO:004867910.9BRAF, PTEN
3cellular response to nerve growth factor stimulusGO:199009010.8BRAF, CALCA, PTEN
4Ras protein signal transductionGO:000726510.8HRAS, NRAS, RASSF1
5hormone biosynthetic processGO:004244610.7DIO2, TG, TPO
6axon guidanceGO:000741110.7HRAS, NKX2-1, NRAS, RET
7MAPK cascadeGO:000016510.6BRAF, HRAS, NRAS, RET
8positive regulation of ERK1 and ERK2 cascadeGO:007037410.6BRAF, HRAS, KDR, PTEN
9animal organ morphogenesisGO:000988710.6BRAF, HRAS, NKX2-1, THRB
10positive regulation of gene expressionGO:001062810.5BRAF, HRAS, NKX2-1, PTEN, RET
11thyroid hormone generationGO:000659010.3DIO2, TPO
12thyroid-stimulating hormone signaling pathwayGO:003819410.2PAX8, TSHR
13thyroid gland developmentGO:003087810.2BRAF, NKX2-1, PAX8, TG
14thyroid hormone metabolic processGO:004240310.1DIO2, TG
15signal transductionGO:00071659.5BRAF, HRAS, NRAS, PPARG, RASSF1, RET

Molecular functions related to Thyroid Cancer, Nonmedullary, 2 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1thyroid-stimulating hormone receptor activityGO:000499610.2PAX8, TSHR
2inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activityGO:005171710.1MINPP1, PTEN

Sources for Thyroid Cancer, Nonmedullary, 2

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet